SCHEMBL7987956

SCHEMBL7987956

CCOc1ccc(N)c(Nc2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.49
MEN1 O00255 4/20 0.49
NPC1 O15118 2/20 0.49
APOBEC3G Q9HC16 1/20 0.49
KDM4E B2RXH2 5/20 0.49
MAPT P10636 4/20 0.49
GAA P10253 4/20 0.49
ALDH1A1 P00352 3/20 0.49
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.47
HTT P42858 3/20 0.46
RAB9A P51151 3/20 0.46
THRB P10828 1/20 0.46
RECQL P46063 1/20 0.46
MMP14 P50281 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11352030 0.88 GAA (0.49) KMT2AMEN1NPC1APOBEC3GKDM4E
SCHEMBL22102774 0.86 KMT2A (0.50) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL8885417 0.86 MAPT (0.56) KMT2AMEN1NPC1APOBEC3GKDM4E
SCHEMBL4892335 0.85 KMT2A (0.46) KMT2AMEN1NPC1APOBEC3GKDM4E
SCHEMBL4899234 0.83 ALDH1A1 (0.51) KMT2AMEN1NPC1APOBEC3GKDM4E
SCHEMBL28501781 0.83 EPHX1 (0.52) KMT2AKDM4EMAPTGAAALDH1A1
SCHEMBL8883131 0.82 POLB (0.47) KMT2AMEN1NPC1APOBEC3GKDM4E
SCHEMBL2817959 0.82 GAA (0.63) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL5832931 0.81 MAPT (0.66) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL8884143 0.81 CYP3A4 (0.46) KMT2AMEN1NPC1APOBEC3GMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed